InvestorsHub Logo
Followers 28
Posts 4990
Boards Moderated 0
Alias Born 01/07/2020

Re: None

Saturday, 08/29/2020 9:26:39 AM

Saturday, August 29, 2020 9:26:39 AM

Post# of 424557
A good day for Amarin and shareholders :)
-------------------

A lot of medecin people also on Yahoo - borrowed this fine input from there:

Thanks to Dr. Jim


[quote: Dr. Jim - 21 hours ago

Observations from the front line -

I'm an ER Doc covering shifts at several smaller Iowa hospitals for the last 15 years. 25 yr FP prior.
I have seen NO Vascepa Rxs thus far. I see several patients per shift that would be good candidates. The market is enormous and has not yet begun to be tapped in my region. Docs just have not been informed and educated yet. I suspect this is true in most areas. When the information filters to this level by Amarn reps, medical society guidelines, articles in review and specialty journals, DTC ads, etc.-- Katy bar the door! When informed, docs will readily prescribe. When they hear the story, they will prescribe "Do Not Substitute" for those indications that have patent protection. They will not be sympathetic to the generics trying to scavenge. Payers will cover for appropriate indications. Even if the appeal is lost, the Reduce-It prevention indication is 4X larger than the elevated TG indication (at issue in the law suit). Win or lose this goes up after the appeal is resolved (perhaps after a temporary dip after a loss).
Lose, more gradual increase as sales/earnings increase. Win, rocket takes off in anticipation of BO.][/quote]
Jasbg
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News